Vicarious Surgical Inc.

RBOTOTCHealthcare● Active

$0.55

+$0.01(+2.54%)

Market Cap$3558625

P/E Ratio—

52W High$13.746

52W Low$0.27

Avg Volume40K

Open$0.55

Beta1.77

Forecast Market Cap PE Ratio

Vicarious Surgical Inc.（RBOT）股价预测与分析师目标价

华尔街共识、12 个月目标价、模型推演与 EPS/营收预期 — 来自分析师数据与历史行情。

rbot · 股价预测 · 5 位分析师（近3月）· FMP · 更新于 2026年6月9日

分析师评级与共识

基于过去 3 个月内 5 位华尔街分析师

Hold

5 位分析师

共识

评级分布

Strong Buy

Buy

Hold

Sell

Strong Sell

合计: 5 · 买入占比: 40.0%

12 个月目标价

High

$10.50

Consensus

$8.75

+1490.9% upside

Low

$7.00

Median: $8.75 · Last Close: $0.55

Vicarious Surgical Inc.（RBOT）的分析师共识为 Hold，基于过去 3 个月内 5 位华尔街分析师的评级。RBOT 的 12 个月平均目标价为 $8.75，相对当前价 $0.55 代表 +1490.9% 的潜在上行空间。

12 个月目标价预测

历史收盘价 + 分析师 12 个月目标价预测区间

分析师目标价覆盖不足，无法为该股票生成预测图表。

短期股价预测

算法生成 · 每日更新

Date	Predicted Price	Change	Min	Max
2026-06-10	$0.52	↓ 5.00%	$0.51	$0.53

1-day model range: $0.51–$0.53. Peak: $0.53 (-5.00%).

长期股价预测

⚠️ 在满 252 个交易日历史（IPO/上市时间较短）前不展示长期预测；短期标签页仍可能显示模型输出。

基于技术分析的股价预测

14 项技术面信号（SMA×6 + EMA×6 + RSI + MACD）· EEAT 方法论透明

Market Sentiment

BEARISH

Based on 14 technical indicators

0%36%64%

0Buy

5Neutral

9Sell

RSI (14)33.4Neutral

MACDBEARISH

Refreshes daily from EOD close

Moving Averages · RBOT · Jun 9, 2026

Simple Moving Average (SMA)

MA 5$0.64SELL

MA 10$0.78SELL

MA 20$0.78SELL

MA 50$0.70SELL

MA 100$0.00NEUTRAL

MA 200$0.00NEUTRAL

Current $RBOT · Price above MA = BUY signal

Exponential Moving Average (EMA)

EMA 5$0.64SELL

EMA 10$0.71SELL

EMA 20$0.73SELL

EMA 50$0.74SELL

EMA 100$0.00NEUTRAL

EMA 200$0.00NEUTRAL

Current $RBOT · Price above MA = BUY signal

How we calculate: Technical sentiment is derived from 14 indicators — SMA(5,10,20,50,100,200), EMA(5,10,20,50,100,200), RSI(14), and MACD(12,26,9) — calculated from historical EOD price data. BUY = current price above MA; SELL = below. 14 TA signals + historical EOD price data · Updated daily. Independent of analyst consensus data. Not investment advice.

最新分析师评级与调整

Filter:

Date	Brokerage	Action	Rating
2024-08-13	Piper Sandler	Maintains	Neutral→Neutral
2024-03-05	Piper Sandler	Maintains	Neutral→Neutral
2023-11-14	BTIG	Downgrade ↓	Buy→Neutral
2023-11-14	Canaccord Genuity	Downgrade ↓	Buy→Hold
2023-05-31	Canaccord Genuity	Maintains	Buy→Buy
2022-07-18	BTIG	Maintains	Buy→Buy
2022-05-10	Piper Sandler	Maintains	Neutral→Neutral
2022-03-04	Canaccord Genuity	Maintains	Buy→Buy
2022-03-04	Piper Sandler	Downgrade ↓	Overweight→Neutral
2022-01-07	Credit Suisse	Maintains	Outperform→Outperform

Piper Sandler2024-08-13

Maintains

Neutral→Neutral

Piper Sandler2024-03-05

Maintains

Neutral→Neutral

BTIG2023-11-14

Downgrade ↓

Buy→Neutral

Canaccord Genuity2023-11-14

Downgrade ↓

Buy→Hold

Canaccord Genuity2023-05-31

Maintains

Buy→Buy

BTIG2022-07-18

Maintains

Buy→Buy

Piper Sandler2022-05-10

Maintains

Neutral→Neutral

Canaccord Genuity2022-03-04

Maintains

Buy→Buy

Piper Sandler2022-03-04

Downgrade ↓

Overweight→Neutral

Credit Suisse2022-01-07

Maintains

Outperform→Outperform

Wall Street analysts have recently issued updated ratings on Vicarious Surgical Inc. (RBOT) stock. Of the recent 14 rating actions, 0 were upgrades and 3 were downgrades. 5 analysts currently cover RBOT.

分析师推荐趋势

Buy ratings0 → 0

Hold ratings1 → 1

Sell ratings0 → 0

RBOT analyst recommendation trends show stable buy-side sentiment over the past 6 months. Buy rating actions changed from 0 to 0 per month.

财务预测：EPS 与营收一致预期

Revenue This Year

$40M

↑ 124.6% YoY

Revenue Next Year

$0M

↓ 100.0% YoY

EPS This Year

$-8.09

EPS Next Year

$-4.07

↓ 49.7% YoY

EPS ForecastReported vs Estimated

Reported EPSHistorical estimateAnalyst forecast (future)

Analysts forecast RBOT EPS of $-8.09 for the current fiscal year, based on estimates from 1 analysts. The RBOT revenue forecast is $40M for the current year. These are analyst consensus estimates via FMP / S&P Global.

关于预测与目标价

RBOT 股价预测由两类独立数据源支撑：来自 5 位华尔街分析师（S&P Global / FMP）的共识评级，以及基于历史日终价计算的技术分析。RBOT 的共识目标价为 $8.75（+1490.9% 上行空间），分析师共识为 Hold。

RBOT 的短期预测（明日）为 $0.52（-5.00%）。

Vicarious Surgical Inc. 在 OTC 上市，代码 RBOT。RBOT 在 2027 年的整体展望偏中性/分化，在覆盖分析师中约 40% 对应 Hold 共识。

常见问题答案综合分析师目标价、一致预期及页面展示的模型结果。

常见问题

RBOT 预测 · 8 个问题

根据 5 位华尔街分析师，RBOT 的 12 个月平均目标价为 $8.75，最高 $10.50、最低 $7.00。若有图表，中位目标价可在上方查看。相对当前价 $0.55，隐含约 +1490.9% 的上行空间。

RBOT 目标价RBOT 分析师目标价RBOT 12个月目标价目标价 RBOT

· Analyst data: Financial Modeling Prep (FMP) · S&P Global Market Intelligence · Technical analysis: FMP /historical-price-eod/light · Updated: Hourly (analyst) · Daily (technical)

⚠ This information is provided for informational purposes only and does not constitute investment advice. Short-term and long-term price predictions are algorithmically generated and carry significant uncertainty. Past performance does not guarantee future results. Always conduct your own due diligence before making investment decisions.